MLIP
Muscular LMNA-interacting protein
Also known as: C6orf142, CIP, MGC18257, MLIP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VWP3
- Gene
- MLIP
- Ensembl
- ENSG00000146147
- Chromosome
- 6
- Canonical length
- 993 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane
OverviewNCBI Gene
Predicted to enable lamin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of cardiac muscle hypertrophy in response to stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Predicted to be located in PML body; nuclear envelope; and sarcolemma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
993 residues, UniProt reviewed canonical sequence.
>Q5VWP3|MLIP
1 MLSEQGLLSD CGNNYFQMTS CILSGSIQTT PQVSAGGSEA KPLIFTFVPT VRRLPTHTQL
61 ADTSKFLVKI PEESSDKSPE TVNRSKSNDY LTLNAGSQQE RDQAKLTCPS EVSGTILQER
121 EFEANKLQGM QQSDLFKAEY VLIVDSEGED EAASRKVEQG PPGGIGTAAV RPKSLAISSS
181 LVSDVVRPKT QGTDLKTSSH PEMLHGMAPQ QKHGQLTSSP TTSEQLACKP PAFSFVSPTN
241 PNTPPDPVNL EGASVLEEFH TRRLDVGGAV VEESATYFQT TAHSTPFSAS KGTSSTLLFP
301 HSTQLSGSNL PSSTAADPKP GLTSEVLKKT TLTSHVLSHG ESPRTSSSPP SSSASLKSNS
361 ASYIPVRIVT HSLSPSPKPF TSSFHGSSST ICSQMSSSGN LSKSGVKSPV PSRLALLTAI
421 LKSNPSHQRP FSPASCPTFS LNSPASSTLT LDQKEKQTPP TPKKSLSSCS LRAGSPDQGE
481 LQVSELTQQS FHLPVFTKST PLSQAPSLSP TKQASSSLAS MNVERTPSPT LKSNTMLSLL
541 QTSTSSSVGL PPVPPSSSLS SLKSKQDGDL RGPENPRNIH TYPSTLASSA LSSLSPPINQ
601 RATFSSSEKC FHPSPALSSL INRSKRASSQ LSGQELNPSA LPSLPVSSAD FASLPNLRSS
661 SLPHANLPTL VPQLSPSALH PHCGSGTLPS RLGKSESTTP NHRSPVSTPS LPISLTRTEE
721 LISPCALSMS TGPENKKSKQ YKTKSSYKAF AAIPTNTLLL EQKALDEPAK TESVSKDNTL
781 EPPVELYFPA QLRQQTEELC ATIDKVLQDS LSMHSSDSPS RSPKTLLGSD TVKTPTTLPR
841 AAGRETKYAN LSSPSSTVSE SQLTKPGVIR PVPVKSRILL KKEEEVYEPN PFSKYLEDNS
901 DLFSEQDVTV PPKPVSLHPL YQTKLYPPAK SLLHPQTLSH ADCLAPGPFS HLSFSLSDEQ
961 ENSHTLLSHN ACNKLSHPMV AIPEHEALDS KEQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MLIP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 205 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 205 nTPM
- heart muscle: 186 nTPM
- tongue: 140 nTPM
- liver: 120 nTPM
- skin: 16 nTPM
- esophagus: 12 nTPM
Single-cell type
- thymic myoid cells: 4,190 nCPM
- myonuclei: 3,507 nCPM
- cardiomyocytes: 2,540 nCPM
- hepatocytes: 281 nCPM
- ependymal cells: 164 nCPM
- bergmann glia: 152 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 89 nTPM
- basal ganglia: 50 nTPM
- white matter: 45 nTPM
- amygdala: 35 nTPM
- thalamus: 25 nTPM
- hippocampal formation: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MLIP.
Disease | AllUniProt
Conditions MLIP is implicated in, by any mechanism.
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1 (MMCKR1) MIM:620138
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 90 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis
- Intellectual developmental disorder, autosomal dominant 64
- MLIP-related disorder
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.71
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cardiac muscle hypertrophy
- negative regulation of cardiac muscle hypertrophy in response to stress
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Muscular LMNA-interacting protein
- Muscular LMNA-interacting protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MLIP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MLIP as an antibody target. Whether an autoantibody or antibody against MLIP could matter depends on whether native MLIP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MLIP is annotated at the cell surface, where native MLIP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MLIP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...